Peripheral Metabolic Function in Chronic Heart Failure Patients
2016年4月4日 更新者:Anders Rasmussen Rinnov
Peripheral Metabolic Function in Chronic Heart Failure Patients: Key to Lessen the Cardiac Load
Exercise intolerance is a major limiting symptom in patients with CHF.
However the poor correlation between the hemodynamic parameters of left ventricular performance at rest and exercise performance has led to the concept that peripheral factors such as muscle perfusion and muscle metabolism play a role as determinants of exercise capacity.
研究概览
详细说明
The pathophysiology behind the breathlessness and fatigue experienced by CHF patients during exercise remains unclear.
Recent evidence suggests that the peripheral skeletal muscle, which becomes abnormal in heart failure, is the source of afferent signals which disrupt normal patterns of cardiorespiratory control.
When CHF patients exercise, an inappropriately strong sympathetic response further limits exercise tolerance by evoking larger than normal increases in peripheral sympathetic activation at a faster rate than in healthy individuals.
A consequence of this exacerbated sympathetic response may be the further sympathetic restraint of blood flow to the active skeletal muscles resulting in hypoperfusion of the muscle vascular bed and fatigue.
Small muscle mass exercise training increases muscle oxidative capacity and improves aerobic work capacity in CHF patients.
A range of studies is proposed here that will provide an integrative view of the mechanistic basis behind exercise intolerance in CHF and relate the intramuscular metabolic status to the autonomic control of hemodynamics during exercise.
An understanding of the mechanistic basis of the improved exercise tolerance with training, independent of improved resting cardiac function, will yield important information regarding the integrated control of blood flow and metabolic demand in CHF and highlight the importance of maintaining the integrity of the peripheral musculature in CHF.
研究类型
介入性
注册 (预期的)
60
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Copenhagen、丹麦、2100
- 招聘中
- Centre of Inflammation and Metabolism (CIM), Centre for Physical Activity Research
-
接触:
- Gregers W Munch, MSc PhD
- 电话号码:+45 35459574
- 邮箱:gregers.munch@regionh.dk
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
40年 至 70年 (成人、年长者)
接受健康志愿者
是的
有资格学习的性别
全部
描述
Inclusion Criteria:
- New York Heart Association (NYHA) Class II - III
- Ejection fraction <35%
- Heart failure as a result of previous myocardial infarction
- Optimal treatment (ACE-inhibitors, beta-blockers)
- Stable heart failure
- Patients with and without implantable cardioverter defibrillator (ICD)
Exclusion Criteria:
- Peripheral vascular disease with symptoms of atherosclerosis (intermittent claudication)
- Aneurysm in a. femoral
- Moderate to severe heart valve disease
- Moderate to severe Chronic Obstructive Pulmonary Disease (COPD) with FEV1 <60%
- Heart Failure Patients with Biventricular pacemaker (BVP)
- Serious heart rhythm disturbances (arrhythmias such as atrial fibrillation and frequent premature ventricular contractions)
- Myocardial infarction within the last month
- Unstable angina (angina pectoris)
- Renal failure (creatinine greater than 2.5 mg / dL)
- Severe systemic disease of the nervous system, pulmonary or other severe organ involvement
- BMI> 30
- Pregnancy
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Exercise training - Whole body exercise
Control subjects will train 2-legged cycling (whole body exercise) for 6 weeks
|
All gruoups will undergo 6 weeks of training intervention either with a small musclemass (one-legged exercise) or whole body exercise (two-legged cycling)
|
|
实验性的:Exercise training - One-legged exercise
Control subjects will train high intense one-legged exercise for 6 weeks
|
All gruoups will undergo 6 weeks of training intervention either with a small musclemass (one-legged exercise) or whole body exercise (two-legged cycling)
|
|
实验性的:Exercise training - 2-legged cycling CHF
CHF patients will train 2-legged cycling (whole body exercise) for 6 weeks
|
All gruoups will undergo 6 weeks of training intervention either with a small musclemass (one-legged exercise) or whole body exercise (two-legged cycling)
|
|
实验性的:Exercise training - CHF
CHF Patients will train high intense one-legged exercise for 6 weeks
|
All gruoups will undergo 6 weeks of training intervention either with a small musclemass (one-legged exercise) or whole body exercise (two-legged cycling)
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline sympathetic nerve activity after 6 weeks of training
大体时间:6 weeks
|
Sympathetic nerve activity, measured in plasma and dialysat with reference to nor-adrenaline.
|
6 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
The effect of exercise training on exercise capacity in regards to oxygen uptake
大体时间:6 weeks
|
Exercise capacity in regards to oxygen uptake (VO2peak) will be evaluated before and after the training intervention
|
6 weeks
|
|
The effect of exercise training on exercise capacity in regards to maximal workload
大体时间:6 weeks
|
Exercise capacity in regards to Workload during 2-legged cycling (Wattpeak) will be evaluated before and after the training intervention
|
6 weeks
|
|
The effect of exercise training on exercise capacity in regards to a 6 min walk test
大体时间:6 weeks
|
Exercise capacity in regards to a 6 min walk test (meters) will be evaluated before and after the training intervention
|
6 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 学习椅:Stefan P Mortensen, Dr. Med、IMM - Department of Cardiovascular and Renal Research
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2014年2月1日
初级完成 (预期的)
2016年8月1日
研究完成 (预期的)
2016年8月1日
研究注册日期
首次提交
2014年11月6日
首先提交符合 QC 标准的
2016年4月4日
首次发布 (估计)
2016年4月11日
研究记录更新
最后更新发布 (估计)
2016年4月11日
上次提交的符合 QC 标准的更新
2016年4月4日
最后验证
2016年4月1日
更多信息
与本研究相关的术语
其他研究编号
- VEK-H-3-2013-048
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.